Teleflex (TFX) revenue

Revenue · fiscal 2025
$1.99B

Teleflex (TFX) reported revenue of $1.99B in fiscal 2025 (the year ended December 31, 2025). That is 17.2% higher than the $1.70B of fiscal 2024. Figures as of 18 Nov 2026, 08:54 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$1.99B
Change on fiscal 2024
+17.2%
Growth, 5 years
−4.7% a year
Growth, 10 years
+1.0% a year
Highest on record
$2.81Bfiscal 2021
Lowest on record
$1.40Bfiscal 2010
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Teleflex revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 4.7% a year; over ten years the rate was 1.0% a year. Across the 18 fiscal years on record (2008–2025), the highest was $2.81B in fiscal 2021 and the lowest $1.40B in fiscal 2010.

History · 18 fiscal years

Revenue by fiscal year

Teleflex revenue, year by year

Teleflex (TFX) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$1.99B 17.2% up
2024$1.70B 0.8% down
2023$1.71B 38.6% down
2022$2.79B 0.7% down
2021$2.81B 10.7% up
2020$2.54B 2.2% down
2019$2.60B 6.0% up
2018$2.45B 14.1% up
2017$2.15B 14.9% up
2016$1.87B 3.2% up
2015$1.81B 1.6% down
2014$1.84B 8.5% up
2013$1.70B 9.4% up
2012$1.55B 3.9% up
2011$1.49B 6.8% up
2010$1.40B 2.6% down
2009$1.43B 25.0% down
2008$1.91B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Teleflex and comparable companies
CompanyRevenueFiscal year
Ligand Pharmaceuticals LGND$268.09M2025
Scholar Rock Holding SRRK$33.19M2022
Teleflex TFX$1.99B2025
Mirum Pharmaceuticals MIRM$521.31M2025
Grifols GRFS€7.52B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TFX

Teleflex, figure by figure

Teleflex (TFX) overview: price, valuation and scorecardAll health care companies by market value

Teleflex revenue: questions and answers

What is Teleflex's revenue?

Teleflex (TFX) reported revenue of $1.99B in fiscal 2025 (the year ended December 31, 2025). That is 17.2% higher than the $1.70B of fiscal 2024.

What is the growth rate of Teleflex's revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 4.7% a year; over ten years the rate was 1.0% a year.

What are the highest and lowest revenue figures on record for Teleflex?

Across the 18 fiscal years on record (2008–2025), the highest was $2.81B in fiscal 2021 and the lowest $1.40B in fiscal 2010.

How is Teleflex's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Teleflex it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Teleflex (TFX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/TFX/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.